Related Experiment Video
Updated: Jul 3, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
Empty Versus Full Bladder Protocols in Radiotherapy Planning for Localised Prostate Cancer: A Dosimetric Study
Rebecca Louise Nield1,2, Sagar Ramani1,2, David Robert Harry Christie1,2,3
1GenesisCare, Southport, Queensland, Australia.
Background:
When planning prostate radiotherapy, full bladder preparation is widely used to displace bowel and bladder from high-dose regions but is difficult to reproduce and can prolong workflows.
Methods:
Twenty men with localised prostate cancer ± seminal vesicles underwent CT simulation with full and empty bladders. VMAT plans prescribing 60Gy in 20 fractions, with simultaneous integrated boost to 66Gy for Dominant intraprostatic lesions where indicated, were created on both datasets. Bladder, rectum, CTV and PTV were compared; dose-volume histogram (DVH) endpoints included V30 and V60. Paired t-tests (two-sided α = 0.05) were used to assess differences.
Results:
Bladder volumes were significantly lower with the empty-bladder preparation (median 126.4 cm3; range 49.0-246.3; p < 0.001) versus full bladder (median 276.0 cm3; range 159.3-625.7). CTV volumes were comparable (empty 65.9 cm3 vs. full 62.8 cm3; p = 0.100). CTV dose was slightly reduced with empty bladder (60.0 Gy vs. 60.1 Gy; p < 0.001), a statistically significant but clinically negligible difference, while PTV coverage (D50%) remained similar (60.5 vs. 60.3 Gy; p = 0.365). Bladder V30 was higher with an empty bladder (26.9% vs. 20.7%; p < 0.001), while V60 was comparable (0.8% vs. 1.0%; p = 0.368). In contrast, rectal V30 was lower with an empty bladder (15.6% vs. 19.9%; p = 0.002), and V60 was low in both groups (0.1% vs. 0.4%; p = 0.077).
Conclusions:
Empty bladder planning maintained target coverage, increased bladder V30, and reduced rectal V30, with all other dose constraints satisfied. This approach may enhance comfort and efficiency without compromising dosimetry.
More Related Videos
09:49A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
Published on: April 24, 2020
07:25A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018